RT @ogcnice: Dans les coulisses de la signature de Mohamed Abdelmonem 👀🇪🇬

Injecting some humor into your day 🤭. While we're here to support you on your advanced therapies journey, we also believe in making it a whole lot of fun!

Join millions who have switched to Grok.

What were the buzzworthy topics at BIO 2024? 🌟. 👉 mRNA.👉 Viral vectors.👉 Cell therapies. We caught up with Christoph Winterhalter, CBO of AGC Biologics, to dive into the exciting world of advanced therapies and the future of our industry.

What were the buzzworthy topics at BIO 2024? 🌟. 👉 mRNA.👉 Viral vectors.👉 Cell therapies. We caught up with Christoph Winterhalter, CBO of AGC Biologics, to dive into the exciting world of advanced therapies and the future of our industry.

A cell line aimed at quickly advancing candidates to clinical trials. And it's just one part of our newest cell line offering. Be one of the first to take AAV manufacturing into the future 👉 #AAV.#GeneTherapy

Looking forward to seeing you in sunny San Diego for BIO 2024!. Chat with us in person at Booth #3221 and let's explore how Cytiva can help you accelerate your therapies from discovery to delivery!

Our NEW Sefia cell therapy manufacturing platform is here. An end-to-end cell therapy manufacturing platform that’s flexible to meet your process needs and is easy to integrate. 📅 Register now for our virtual launch event:

Hear insights about solutions paving the way for enhanced patient access to groundbreaking therapies with Emmanuel Abate, President of Genomic Medicine at Cytiva, and Dr. Nathaniel Wang, CEO and Co-Founder of Replicate Bioscience. Register now:

It's here - the Sefia platform designed to accelerate the manufacture of autologous CAR T cell therapies. Read more about it here.

Headed to #BIO2024 this June? Book a meeting with us to discuss how we can work together to advance your therapeutic from research, development, and manufacturing ― to patients. More on how to connect with us during the event here:

⭐We’re hiring! ⭐. Ready to take your career viral? We might just have the perfect role. Advance your career and be part of something altogether life-changing. Let’s work together:

Say hello to Sefia!. Sefia is our new cell therapy manufacturing platform developed to tackle challenges with manufacturing autologous CAR T cell therapies. Read more now.

Ready to push the boundaries of AAVs?. Our ELEVECTA cell line portfolio offers a range of options - providing the opportunity to tailor your choice for each therapeutic program. Seamlessly transition from R&D through manufacturing. Let's talk 👉

🚀 Introducing our latest T-series cassettes with 100 kDa Delta membrane for concentration and diafiltration for RNA and LNP applications – an excellent addition for your mRNA workflow. Read our app note now:

🌟 Join Emmanuel Abate, President of Genomic Medicine at Cytiva, and our stellar guest from Replicate Bioscience LIVE at #BIO2024! . Register here to watch our broadcast on 4 June: #WeAreCytiva .#AdvancedTherapies

🎉 Hey there, pioneers of advanced therapies! 🚀 . Get ready to dive into the heart of the action at #BIO2024, where we're bringing you a LIVE discussion on propelling advanced therapies into the spotlight! .Register here to watch our broadcast:

🚀 What's the winning formula for success in the advanced therapies pipeline? . Find out first-hand from Dr. Nathaniel Wang, CEO and Co-Founder of Replicate Biosciences. 🧬 . Tune in to our live broadcast:

Navigating the maze of GMP standards in cell therapy manufacturing can feel overwhelming, especially with cutting-edge therapies like CAR T. But guess what? You don’t have to tackle it alone! . Let’s team up and bring advanced therapeutics to patients faster! 🚀

RT @rosaadam0: لاول مره بطلب من الاصدقاء اعاده نشر الصوره على حساباتهم. جزيل الشكر . #GAZA - 26 May.#RAFAH

Lighten up your day with a dose of humor! 🤭. We all need a break from the seriousness of work sometimes, so here's a little chuckle for you.